EUVIMEDEUVIMED entdecken
VergleichsstudieStudienprotokoll

Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol

Ishaan P Dharia, Emily A Leven, Natalia Schmidt, Haley Waite, Pu Ni, M Isabel Fiel, Marcelo E Facciuto, Thomas D Schiano, Lauren T Grinspan

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70685 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Ishaan P Dharia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) is uncommon but associated with poor outcomes, requiring effective surveillance. We assessed adherence to and effectiveness of a risk‐stratified surveillance protocol and compared it with the RETREAT‐guided surveillance protocol.

Methods

We performed a single‐center retrospective review of patients with HCC on explant after LT (2013–2023). Patients were assigned low‐ or high‐risk surveillance based on explant pathology (AJCC tumor stage, grade, and vascular invasion). Protocol performance, modified surveillance strategies, and comparison with RETREAT across multiple cutoffs were assessed.

Results

Among 480 patients, 55 (11.5%) developed recurrence; 23 (41.8%) of these died, with median post‐recurrence survival of 14 months. Only 15.8% were fully adherent, with higher adherence in low‐risk patients ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCarcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesFollow-Up StudiesMiddle AgedPrognosisRisk FactorsSurvival RateRisk Assessment

Stichwörter der Autor:innen

HCCliver transplantationprotocolsurveillance

Autor:innen und Institutionen

  • Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, New York, USA.
  • Department of Pathology, Mount Sinai West and Morningside, New York, New York, USA.
  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Zitieren

APA

Dharia, I. P., Leven, E. A., Schmidt, N., Waite, H., Ni, P., Fiel, M. I., Facciuto, M. E., Schiano, T. D., & Grinspan, L. T. (2026). Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol. Clinical Transplantation. https://doi.org/10.1111/ctr.70685

Vancouver

Dharia IP, Leven EA, Schmidt N, Waite H, Ni P, Fiel MI, et al. Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol. Clinical Transplantation. 2026. doi:10.1111/ctr.70685

BibTeX
@article{Dharia2026,
  author = {Dharia, Ishaan P and Leven, Emily A and Schmidt, Natalia and Waite, Haley and Ni, Pu and Fiel, M Isabel and Facciuto, Marcelo E and Schiano, Thomas D and Grinspan, Lauren T},
  title = {Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70685}
}
Kostenlos starten →